Cargando…
Prenatal diagnosis of trisomy 8 mosaicism, initially identified by cffDNA screening
BACKGROUND: So called cell-free fetal DNA (cffDNA) in the maternal plasma, which is derived from placenta, is widely used to screen fetal aneuploidies, including trisomy 21, 18, 13 and sex chromosomes. Here we reported a case of trisomy 8 mosaicism (T8M), which was initially identified via cffDNA sc...
Autores principales: | Hu, Junjie, Yan, Kai, Jin, Pengzhen, Yang, Yanmei, Sun, Yixi, Dong, Minyue |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9434846/ https://www.ncbi.nlm.nih.gov/pubmed/36050777 http://dx.doi.org/10.1186/s13039-022-00616-y |
Ejemplares similares
-
Cell-Free Fetal Deoxyribonucleic Acid (cffDNA) Analysis as a Remarkable Method of Non-Invasive Prenatal Screening
por: Raj, Himanshu, et al.
Publicado: (2022) -
Prenatal diagnosis of a trisomy 7/trisomy 13 mosaicism
por: Huijsdens-van Amsterdam, Karin, et al.
Publicado: (2012) -
The significance of trisomy 7 mosaicism in noninvasive prenatal screening
por: Qi, Yiming, et al.
Publicado: (2019) -
Clinical Efficiency of Non-invasive Prenatal Screening for Common Trisomies in Low-Risk and Twin Pregnancies
por: Xu, Yanfei, et al.
Publicado: (2021) -
Inherited unbalanced reciprocal translocation with 3q duplication and 5p deletion in a foetus revealed by cell-free foetal DNA (cffDNA) testing: a case report
por: Ali, Taccyanna M., et al.
Publicado: (2021)